Back to 
Polar Capital Holdings Plc
Polar Capital Holdings Plc
CYTK
23 quarters
Position history for Polar Capital Holdings Plc's holdings in Cytokinetics, Incorporated
Yes. Polar Capital Holdings holds 2,253,649 shares of CYTK (Cytokinetics), worth $192M, as of its Q2 2026 13F filing. It increased the position by 592,401 shares (+35.7%) from Q1 2026. Polar Capital Holdings has held CYTK in every 13F on record since Q4 2020, 23 quarterly filings. CYTK is 0.5% of Polar Capital Holdings' reported 13F portfolio.
Current Value
$192M
Current Shares
2.3M
Total Value Change
+$124M
Total Shares Change
-1M
Quarter-by-Quarter History
Other major holders of CYTK: BlackRock, Inc., BlackRock Finance, Inc., FMR LLC